Colorectal Cancer Clinical Trials in Austin, TX

Colorectal Cancer Clinical Trials in Austin, TX

View the best 10 colorectal cancer medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Austin, Texas

Here are the top 10 medical studies for colorectal cancer in Austin, Texas

Image of Weill Cornell Medical College in New York, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Ceralasertib +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 1
This trial will find the best dose and safety of ceralasertib when given with trastuzumab deruxtecan to treat patients with solid tumors that have a change in the HER2 gene or protein.
Image of University of Toledo, Eleanor N. Dana Cancer Center in Toledo, United States.

NBF-006

Recruiting1 awardPhase 1
This trial is testing a new cancer treatment to see if it is safe and effective. The first part of the trial is to see what dose is safe, and the second part is to see if the treatment works.
Image of START Midwest, LLC in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, NGM707, as a possible treatment for advanced solid tumors. It will be tested alone and in combination with another cancer drug, pembrolizumab.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of Alabama Oncology, Bruno Cancer Center in Birmingham, United States.

mFOLFOX6 Regimen +3 More

Small Molecule

Recruiting2 awardsPhase 3
This trial is testing a new drug, MRTX849, to see if it is better than chemotherapy at treating colorectal cancer that has a KRAS G12C mutation.
Image of Dignity Health St Joseph's Hospital and Medical Center in Phoenix, United States.

Entrectinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, entrectinib, for patients with different types of solid tumors that have a gene fusion. Patients will be assigned to different groups depending on their tumor type and gene fusion.
Image of The University of Arizona Cancer Center (UACC) - North Campus in Tucson, United States.

SM08502

Chemotherapy

Recruiting1 awardPhase 1
This trial is testing a new drug, SM08502, for safety and effectiveness in treating advanced solid tumors, either alone or in combination with other cancer treatments.
Image of Carta - Clinical Associates in Research Therapeutics of America, LLC in San Antonio, United States.

Ponsegromab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial will test if a new drug is effective, safe, and tolerable for treating cancer-related cachexia and elevated GDF 15 levels.
Image of The University of Texas MD Anderson Cancer Center in Houston, United States.

TTI-101

STAT3 Inhibitor

Recruiting1 awardPhase 1
This trial will test a new compound, TTI-101, which is a direct inhibitor of the protein STAT3. This protein is involved in the development and growth of many types of cancer, but there is no current drug that targets it. TTI-101 will be given orally to patients with various types of solid tumors, to determine if it is safe and effective in reducing the growth of these tumors.

Popular filter options for colorectal-cancer austin trials

Phase 3 Clinical Trials

View 61 phase 3 medical studies.

Clinical Trials With No Placebo

View 61 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.